GI
RMD icon

GAMMA Investing’s ResMed RMD Stock Holding History

GAMMA Investing’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$711K Sell
3,646
-744
-17% -$154K 0.03% 508
2026
Q1 		$985K Buy
4,390
+99
+2% +$24.7K 0.05% 348
2025
Q4 		$1.03M Sell
4,291
-107
-2% -$27.4K 0.05% 302
2025
Q3 		$1.2M Buy
4,398
+555
+14% +$152K 0.07% 245
2025
Q2 		$991K Buy
3,843
+566
+17% +$135K 0.06% 273
2025
Q1 		$734K Buy
3,277
+231
+8% +$53.9K 0.06% 306
2024
Q4 		$697K Buy
3,046
+545
+22% +$131K 0.06% 283
2024
Q3 		$611K Buy
2,501
+1,177
+89% +$263K 0.06% 284
2024
Q2 		$253K Buy
1,324
+476
+56% +$96.6K 0.03% 436
2024
Q1 		$168K Buy
848
+199
+31% +$36.5K 0.03% 450
2023
Q4 		$123K Buy
+649
New +$99.7K 0.03% 459

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GAMMA Investing's RMD Position: Q2 2026 in Review

GAMMA Investing reduced its ResMed (RMD) stake by 17% in Q2 2026, selling an estimated $154K and leaving 3,646 shares worth $711K. The position accounts for 0.03% of the portfolio, ranked #508.

GAMMA Investing first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.2M in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • GAMMA Investing held 3,646 shares of ResMed worth $711K as of Q2 2026.
  • GAMMA Investing sold 744 ResMed shares in Q2 2026, an estimated $154K.
  • ResMed made up 0.03% of GAMMA Investing's portfolio in Q2 2026, its #508 holding.
  • GAMMA Investing first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's ResMed position peaked at $1.2M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.